Have a personal or library account? Click to login
Factors associated with mortality and high treatment expense of adult patients hospitalized with chronic kidney disease in Thailand Cover

Factors associated with mortality and high treatment expense of adult patients hospitalized with chronic kidney disease in Thailand

Open Access
|Jan 2017

Figures & Tables

Prognostic factors influencing mortality rates of adult Thai patients hospitalized with chronic kidney disease

VariablesNo. of patients (individuals)Dead individuals and mortality rate (%)Crude odds ratio (95% CI)PAdjusted odds ratio* (95% CI)P
Sex
  Female66,1346,814(10.3)1 1
  Male62,2046,941(11.2)1.10(1.05-1.14)<0.0011.07(1.03-1.11)0.001
Age (years)
  19-301,869189(10.1)1 1
  31-404,135400(9.7)0.95(0.79-1.14)0.601.13(0.92-1.39)0.23
  41-5010,5561,127(10.7)1.06(0.90-1.25)0.471.20(1.00-1.45)0.049
  51-6023,0732,318(10.0)0.99(0.85-1.16)0.931.09(0.91-1.30)0.36
  61-7032,8373,277(10.0)0.98(0.84-1.15)0.851.08(0.91-1.29)0.38
  71-8037,7274,039(10.7)1.07(0.91-1.24)0.421.19(0.99-1.41)0.06
  >8018,1412,405(13.3)1.36(1.16-1.59)<0.0011.52(1.27-1.81)<0.001
Comorbidities
  Diabetes mellitus (yes/no)58,427/69,9116,795(11.6)/6,960(10.01.19(1.15-1.23)<0.0011.13(1.08-1.19)<0.001
  Ischemic heart disease (yes/no)19,264/109,0743,178(16.5)/10,577(9.7)1.84(1.76-1.92)<0.0011.64(1.55-1.73)<0.001
  Heart failure (yes/no)18,174/110,1643,277(18.0)/10,478(9.5)2.09(2.01-2.18)<0.0011.42(1.35-1.50)<0.001
  Sepsis (yes/no)16,792/111,5466,146(36.6)/7,609(6.8)7.89(7.58-8.20)<0.0014.96(4.75-5.19)<0.001
  Pneumonia (yes/no)13,247/115,0913,860(29.1)/9,895(8.6)4.37(4.19-4.56)<0.0011.81(1.72-1.91)<0.001
  AKI plus preexisting CKD (yes/no)11,367/116,9712,972(26.1)/10,783(9.2)3.49(3.33-3.65)<0.0011.63(1.54-1.72)<0.001
  Stroke (yes/no)9,527/118,8112,071(21.7)/11,684(9.8)2.55(2.42-2.68)<0.0012.16(2.03-2.30)<0.001
  Respiratory failure (yes/no)10,596/117,7424,707(44.4)/9,048(7.7)9.60(9.19-10.03)<0.0014.14(3.94-4.36)<0.001
Complications
Anemia requiring blood Transfusion (yes/no) 38,730/89,6085,916(15.3)/7,839(8.7)1.88(1.81-1.95)<0.0011.21(1.16-1.27)<0.001
  Hyperkalemia (yes/no)19,165/109,1733,728(19.5)/10,027(9.2)2.39(2.29-2.49)<0.0011.51(1.44-1.59)<0.001
  Volume overload (yes/no)15,213/113,1252,831(18.6)/10,924(9.7)2.14(2.04-2.24)<0.0011.25(1.18-1.32)<0.001
  Metabolic acidosis (yes/no)10,561/117,7772,799(26.5)/10,956(9.3)3.52(3.35-3.69)<0.0011.74(1.64-1.84)<0.001

Characteristics of patients hospitalized with chronic kidney disease

Characteristics of admitted CKD patients
Number of adult patients (individuals)128,338
Number of admissions (times)236,439
Age (mean ± SD) years65.5 ± 13.9
Sex (male/female)1/1.14
Common comorbidities (% of admissions)
  Hypertension53.1
  Diabetes mellitus43.0
  Hyperlipidemia13.2
  Ischemic heart disease12.4
  Heart failure10.5
  Gout8.3
  Sepsis7.8
  Pneumonia6.2
  AKI on preexisting CKD5.1
  Diarrhea5.1
  Stroke5.0
  Respiratory failure4.8
Complications (% of admissions)
  Anemia requiring blood transfusion24.4
  Hyperkalemia9.9
  Volume overload9.3
  Metabolic acidosis5.0
Dialysis treatment (% of admissions)
  Hemodialysis7.3
  Peritoneal dialysis1.9
Length of stay (days)
  Median (25th –75th percentile)3.0 (2.0-6.0)
Hospital charge (baht)
  Mean ± SD20,980 ± 126,985
  Median (25th –75th percentile)7,360 (3,866-16,599)
Mortality (%)10.7

Factors influencing high hospital charges (>50,000 baht) among Thai adult patients hospitalized with CKD

VariablesNo. of admissions (times)No. of high cost admission (%)Crude odds ratio (95% CI)PAdjusted odds ratio (95% CI)P
Sex
  Female126,0278,490(6.7)1 <0.001
  Male110,4129,662(8.8)1.31(1.27–1.36) 1.29(1.25–1.34)
Age (years)
  19–304,376405(9.3)1 1
  31–408,392715(8.5)0.92(0.80–1.06)0.241.03(0.88–1.20)0.72
  41–5022,1721,682(7.6)0.81 (0.72–0.92)<0.0010.90(0.78–1.03)0.13
  51–6046,5713,408(7.3)0.77(0.68–0.86)<0.0010.81(0.71–0.92)0.002
  61–7062,6724,324(6.9)0.72(0.64–0.81)<0.0010.75 (0.66–0.85)<0.001
  71–8064,2885,065 (7.9)0.82(0.72–0.92)<0.0010.84(0.74–0.96)0.01
  >8027,9682,553(9.1)0.95 (0.84–1.07)0.400.95(0.83–1.09)0.48
Comorbidities
  Hypertension (yes/no)125,565/110,87411,037(8.8)/7,115(6.4)1.38(1.34–1.42)<0.0011.21(1.17–1.26)<0.001
  Diabetes mellitus (yes/no)101,664/134,7758,775 (8.6)/9,377 (7.0)1.27(1.23–1.31)<0.0011.20(1.16–1.25)<0.001
  Hyperlipidemia (yes/no)31,229/205,2103,449(11.0)/14,703(7.2)1.51(1.45–1.57)<0.0011.38(1.32–1.45)<0.001
  Ischemic heart disease (yes/no)29,272/207,1674,406(15.1)/13,746(6.6)2.42(2.33–2.51)<0.0012.35 (2.24–2.45)<0.001
  Heart failure (yes/no)24,915/211,5242,679(10.8)/15,473(7.3)1.53(1.46–1.60)<0.0011.13(1.07–1.19)<0.001
  Sepsis (yes/no)18,528/217,9114,586(24.8)/13,566(6.2)4.62(4.44–4.79)<0.0012.87(2.74–3.00)<0.001
  Pneumonia (yes/no)14,732/221,7074,004(27.2)/14,148(6.4)5.18(4.98–5.40)<0.0013.18(3.03–3.34)<0.001
  AKI plus preexisting CKD (yes/no)12,133/224,3063,351(27.6)/14,801(6.6)5.09(4.88–5.31)<0.0012.83 (2.69–2.98)<0.001
  Stroke (yes/no)11,886/224,5532,313(19.5)/15,839(7.1)2.97(2.83–3.12)<0.0012.41 (2.27–2.55)<0.001
  Respiratory failure (yes/no)11,347/225,0923,080(27.1)/15,072(6.7)5.02(4.80–5.25)<0.0012.10(1.99–2.22)<0.001
Complications
  Anemia requiring blood Transfusion (yes/no)57,727/178,7127,442(12.9)/10,710(6.0)2.38(2.31–2.46)<0.0012.13(2.06–2.21)<0.001
  Hyperkalemia (yes/no)23,505/212,9342,532(10.8)/15,620(7.3)1.57(1.51–1.64)<0.0011.09(1.03–1.14)0.002
  Metabolic acidosis (yes/no)11,897/224,5421,549(13.0)/16,603(7.4)1.90(1.80–2.00)<0.0011.03(0.96–1.10)0.42
Mode of dialysis
  Hemodialysis17,143/219,2965,239(30.6)/12,913(5.9)6.45 (6.22–6.70)<0.0015.16(4.94–5.39)<0.001
  Peritoneal dialysis4,584/231,8551,170(25.5)/16,982(7.3)4.16(3.89–4.46)<0.0013.40(3.14–3.69)<0.001

Length of hospital stay and hospital charges for hospitalized patients with chronic kidney disease and comorbidities, complications, and dialysis

Length of stay (days)Total hospital charge (baht)Hospital charge per day (baht)

Median (25th–75th percentile)Mean ± SDMedian (25th–75th percentile)Mean ± SDMedian (25th–75th percentile)
ComorbiditiesHypertension4(2–7)23,333 ±151,9297,759(4,028–17,866)3,564 ±11,4862,182(1,465–3,543)
Diabetes mellitus4(2–7)23,072 ±165,6347,836(4,151–17,566)3,479 ±12,2172,127(1,444–3,482)
Hyperlipidemia4 (2–7)27,754 ±79,1658,767(4,471–20,767)4,283 ±11,5702,232(1,493–3,700)
Ischemic heart disease4(2–8)37,732 ±106,75211,478(5,510–27,252)5,924 ±15,3592,729(1,782–4,597)
Heart failure4(2–8)28,369 ±107,8709,920(5,310–21,368)3,503 ±6,0352,392(1,642–3,787)
Gout4 (2–7)19,727 ±54,7887,061 (3,709–15,541)2,989 ±5,7381,930(1,323–3,095)
Sepsis6 (3–13)54,187 ±140,15119,293 (8,684–19,433)4,789 ±4,8883,412(2,054–5,756)
Pneumonia7(4–14)63,327 ±163,42019,308(8,470–55,465)4,170± 3,7473,118(1,901–5,143)
AKI on pre-existing CKD7 (4–14)57,789 ±127,68522,363(9,794–55,169)4,678 ±6,1663,182(1,995–5,286)
Diarrhea3(2–6)17,199 + 55,4615,557(3,086–11,968)2,390 ±2,7511,684(1,223–2,602)
Stroke5(3–11)44,983 ±116,44813,962(6,644–37,092)4,112 ±6,0662,860(1,826–1,686)
Respiratory failure5(2–11)55,515 ±121,60023,262(10,459–54,127)5,923 ±5,5094,691 (3,260–6,917)
ComplicationsAnemia requiring
blood transfusion4(2–8)29,857 ±97,6879,234(4,591–23,990)3,569 ±4,8302,600(1,828–3,950)
Hyperkalemia4 (2–7)25,446 ±65,6949,324(5,151–21,005)3,775 ±4,9782,696(1,850–1,246)
Volume overload4(2–7)24,277 ±315,2278,960(4,955–19,631)3,391 ±21,0332,372(1,635–3,770)
Metallic acidosis4(2–8)27,833 ±63,34911,010(5,679–25,701)4,432 ±5,5912,942(1,866–5,215)
Mode of dialysisHemodialysis8(4–15)66,302 ±245,69427,847(13,424–61,410)5,864 ±92,3033,470(2,301–5,473)
Peritoneal dialysis8(4–15)56,072 ±369,69021,850(10,218–51,175)6,711 ±177,7882,904(1,900–4,815)
DOI: https://doi.org/10.5372/1905-7415.1001.460 | Journal eISSN: 1875-855X | Journal ISSN: 1905-7415
Language: English
Page range: 15 - 24
Published on: Jan 31, 2017
Published by: Chulalongkorn University
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year

© 2017 Sirirat Anutrakulchai, Cholatip Pongskul, Dhavee Sirivongs, Pantipa Tonsawan, Kaewjai Thepsuthammarat, Sutin Chanaboon, Supannee Promthet, Bandit Thinkhamrop, published by Chulalongkorn University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.